Bundamedik Tbk vs Hetzer Medical Indonesia Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Hetzer Medical Indonesia Tbk. trades at Rp81 (market cap 126.56B, 35.33M 24h volume). The key difference: Bundamedik Tbk is far larger — about 11.9× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (35.33M versus 536.7K). Which is the better fit depends on your goals.
| BMHS | MEDS | |
|---|---|---|
Market Cap | 1.51T | 126.56B |
Volume | 536.7K | 35.33M |
Lot | 5.37K | 353.3K |
Turnover | 93.41M | 2.85B |
Average Price | 174.05 | 80.72 |
Value | 93.41M | 2.85B |
Indicative Equilibrium Price | 176 | 81 |
Indicative Equilibrium Volume | 100 | 16.22K |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →